269
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Alpha-1-Antitrypsin Deficiency in Early Childhood

, &
Pages 312-319 | Published online: 24 May 2011

REFERENCES

  • Pott GB, Chan ED, Dinarello CA, Leland Shapiro. α-1-Antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole blood. J Leukoc Biol 85:886–895, 2009.
  • Petrache I , Fijalkowska I, Zhen L, Medler TR, Brown E, Cruz P, Choe KH, Stewart LT, Scerbavicius R, Shapiro L, Zhang B, Song S, Hicklin D, Voelkel NF, Flotte T, Tuder RM. A novel antiapoptotic role for α1-antitrypsin in the prevention of pulmonary emphysema. Am J Respir Crit Care Med 173:1222–1228, 2006.
  • Weiss G, Goossen B, Doppler W, Fuchs D, Pantopoulos K, Werner-Felmayer G, Wachter H, Hentze MW. Translational regulation via iron-responsive elements by the nitric oxide/NO-synthase pathway. EMBO 12:3651–3657, 1993.
  • Nukiwa T, Satoh K, Brantly ML, Ogushi F, Fells GA, Courtney M, Crystal RG. Identification of a second mutation in the protein-coding sequence of the Z type alpha 1-antitrypsin gene. J Biol Chem 262:11999–12004, 1987.
  • Lomas DA, Evans DL, Finch JJ, Carell RW. The mechanism of Z α1- antitrypsin accumulation in the liver. Nature 357:605–607, 1992.
  • Perlmutter DH. Alpha-1 antitrypsin deficiency. In: Suchy FJ, Balistreri WF, Sokol RJ, eds. Liver Disease in Children. Philadelphia: Lippincott Williams & Wilkins; 2001:523–547.
  • Ogushi F, Fells GA, Hubbard RC, Straus SD, Crystal RG. Z-type α1- antitrypsin is less competent then M1-type a1- antitrypsin as an inhibitor of neutropfil elastase. J Clin Invest 80:1366–1374, 1987.
  • Yoshida A, Ewing C, Wessels M, Lieberman J, Gaidulis, L. Molecular abnormality of PI S variant of human alpha1-antitrypsin. Am J Hum Genet 29:233–239, 1977.
  • Curiel DT, Chytil A, Courtney M, Crystal, RG. Serum α1-antitrypsin deficiency associated with the common S-type (Glu264→Val) mutation results from intracellular degradation of α1-antitrypsin prior to secretion. J Biol Chem 264:10477–10486, 1989.
  • Dorney SF, Hassall EG, Arbuckle SM, Vargas JH, Berquist WE. SZ phenotype alpha-1-antitrypsin deficiency with paucity of the interlobular bile ducts. Aust Paediatr J 23;55–56, 1987.
  • Regev A, Guaqueta C, Torres M. Does the heterozygous state of alpha-1 antitrypsin deficiency have a role in chronic liver diseases? Interim results of a large case-control study. Hepatology 43:S30–35, 2004.
  • Campbell KM, Arya G, Ryckman FC, Alonso M, Tiao G, Balistreri WF, Bezerra JA. High prevalence of α-1-antitrypsin heterozygosity in children with chronic liver disease. J Pediatr Gastroenterol Nutr 44:99–103, 2007.
  • Aboussouan LS, Stoller JK. Detection of alpha-1 antitrypsin deficiency. Respir Med 103:335–341, 2009.
  • Kishimoto Y, Yamada S, Hirayama C. An association between AAT phenotype and chronic liver disease. Hum Genet 84:132–136, 1990.
  • Topic A, Jelic IZ, Spasojevic KV, Spasic S, Stankovic I. Distribution of alpha-1-antitrypsin phenotypes in Serbian newborns and children with liver disease. Acta Paediatr 2002;91:726–727.
  • Laurell CB, Eriksson S. The elestrophoretic alpha1-globuli pattern of serum in alpha1-antitrypsin deficiency. Scand J Clin Lab Investigation 15:132–140, 1963.
  • Sharp HL, Bridges RA, Krivit W, Freier EF. Cirrhosis associated with alpha-1-antitrypsin deficiency: a previously unrecognized inherited disorder. J Lab Clin Med 73:934–939, 1969.
  • Campos MA, Wanner A, Zhang G, Sandhaus RA. Trends in the diagnosis of symptomatic patients with α1-antitrypsin deficiency between 1968 and 2003. Chest 128:1179–1186, 2005.
  • Eriksson S. Alpha 1-antitrypsin deficiency. J Hepatol 30(S1):34–39, 1999.
  • Sveger T, Eriksson S. The liver in adolescents with α1-antitrypsin deficiency. Hepatology 22:1316–1321, 1995.
  • Migliazza L, Santamaria ML, Murcia J, Gamez M, Clavijo J, Camarena C, Hierro L, Frauca E, de la Vega A, Diaz M, Jara P, Tovar JA. Long-term survival expectancy after liver transplantation in children. J Pediatr Surg 235:5–8, 2000.
  • Cottrall K, Cook PJ, Mowat AP. Neonatal hepatitis syndrome and α1-antitrypsin deficiency: an epidemiological study in south-east England. Postgrad Med J 50:376–380, 1974.
  • Henriksen NT, Drablos PA, Aagenaes O. Cholestatic jaundice in infancy: the importance of familial and genetic factors in aetiology and prognosis. Arch Dis Child 56:622–627, 1981.
  • Lomas D, Mahadeva R. α1-antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapy. J Clin Invest 110:1585–1590, 2002.
  • Odièvre M, Martin JP, Hadchouel M, Alagille D, Thaler MM. Alpha1-antitrypsin deficiency and liver disease in children: phenotypes, manifestations, and prognosis. Pediatrics 57:226–231, 1976.
  • Talbot IC, Mowat AP. Liver disease in infancy: histological features and relationship to α1-antitrypsin phenotype. J Clin Pathol 28:559–563, 1975.
  • Mencin A, Ekihiro S, Yosuke O, Kodama Y, De Minicis S, Knowles M, Brenner DA. Alpha-1 antitrypsin Z protein (PiZ) increases hepatic fibrosis in a murine model of cholestasis. Hepatology 46:1443–1452, 2007.
  • Aagenaes Ø, Fagerhol M, Elgjo K, Munthe E, Hovig T. Pathology and pathogenesis of liver disease in alpha-1-antitrypsin deficient individuals. Postgrad Med J 50:365–375, 1974.
  • Nebbia G, Hadchouel M, Odievre M, Alagille D. Early assessment of evolution of liver disease associated with α1-antitrypsin deficiency in childhood. J Pediatr 102:661–665, 1983.
  • Pittschieler K. Liver disease and heterozygous alpha-1-antitrypsin deficiency. Acta Paediatr Scand 80:323–327, 1991.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.